Kintara Therapeutics (KTRA) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Kintara Therapeutics announced a reverse stock split at a 1-for-35 ratio, set to take effect on October 18, 2024, as part of its merger with TuHURA Biosciences. The move will reduce the number of outstanding shares significantly, impacting stockholders uniformly without altering their equity interests. The merged entity will trade under the new name TuHURA Biosciences, Inc. with the symbol ‘HURA’ on Nasdaq.
For further insights into KTRA stock, check out TipRanks’ Stock Analysis page.
